| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |

Enter Drug Name: (Trade  or Generic)



 
 Generic Name  Fenofibrate 
 Trade Name  Tricor 
 Manufacturer   
 Risk Category    
C
  • Studies on animals show adverse effect and toxicity on fetus.
  • No adequate and well controlled studies done on pregnant women.
  • Drugs should be given only if the potential benefit outweighs the potential risk to the fetus.


 Place (not click) your mouse cursor over the bold words in the text below to receive description
 Indication  

  • Antilipemic agent.
 Fetal Risk  

  • Embryodical, fetotoxic and teratogenic in animals at high doses causing increased post-implantation loss, decreased birth weight and post-natal survival, increased incidence of congenital malformations including: visceral, skeletal defects and spina bifida.
  • No adequate human data, should be used only if potential maternal benefit outweighs any risk to the fetus.
 Breast Feeding  

  • Should not be used by lactating women because of the potential for tumorigenicity as seen in animal studies.
 Other Trade Names  
 


Tell A Friend About Tricor

The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.

Home | About us | Drug Search | Maternal exposures | Nutrition | Contact us
How to use | Terms and conditions| Tell A Friend | Calculate Birth Date

Last complete update: 10/05/2006